Agilent Technologies Inc (A) Balance Sheet
A balance sheet shows what a company owns and owes, and shareholders' equity, at a single point in time.
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates through three segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets.
Total Assets Chart for Agilent Technologies Inc
Agilent Technologies Inc (A) total assets for FY2025 were USD 12.7B, a 7.4% change from FY2024. Agilent Technologies Inc's total assets grew from USD 5.0B in 1998 to USD 12.7B in 2025 (155.2% over 27 years). Total assets compound annual growth rate: 5-year CAGR of 5.7%, 10-year CAGR of 5.5%, 20-year CAGR of 3.2%.
Total Assets (US Dollars)
R&D as % of Revenue
Compare with
Key Stats
- Market Cap
- $43.80B
- Implied Share Price
- $155.08
- Enterprise Value
- $45.26B
- Revenue (TTM)
- $7.23B
- EBITDA
- $2.02B
- Profit Margin
- 19.55%
- Trailing P/E
- 31.08
- Forward P/E
- 23.20
- Price/Book (MRQ)
- 6.14
- Price/Sales (TTM)
- 6.06
- EV/EBITDA
- 23.07
- EV/Revenue
- 6.26
- Dividend Yield
- 0.65%
- Book Value
- $25.24
- Free Cash Flow (FY2025)
- $1.15B
- Free Cash Flow Yield
- 2.63%
Snapshot as of 26th August 2026 — not point-in-time controlled, may lag the live market by a few days.